Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT07507864
Recruiting Observational

Validation Of The Turkish Version Of The Oral Assessment Sheet

NCT07507864 · tracked via the Priya Life Science Turkey tracker
Sponsor
Necmettin Erbakan University
Phase
Observational
Started
2026-02-26
Last updated
2026-04-02

Condition(s) studied

Oral Health

Study summary

The aim of this observational study is to evaluate the validity and reliability of the Turkish version of the Oral Assessment Sheet (OAS). The OAS is a clinical assessment tool developed to evaluate oral health conditions such as lips, tongue, mucosa, saliva, swallowing, and voice.

This study will investigate whether the Turkish version of the OAS is a valid and reliable tool for assessing oral health status in clinical practice. Participants will undergo oral assessment using the Turkish version of the OAS. Statistical analyses will be performed to determine the validity and reliability of the scale.

The results of this study are expected to provide a standardized oral assessment tool that can be used in Turkish clinical settings.

Eligibility

Sex
ALL
Min age
60 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Age 60 years or older * Ability to understand Turkish * Voluntary participation and provision of written informed consent * Ability to undergo oral examination and assessment * Adequate cognitive and psychological status Exclusion Criteria: * Individuals who refuse to participate in the study * Individuals who withdraw from the study during the research process * Individuals with severe cognitive impairment preventing completion of the assessment * Individuals with conditions preventing oral examination

Primary outcome measure(s)

  • Validity and Reliability of the Turkish Version of the Oral Assessment Sheet (OAS) — Baseline and 1-2 weeks
    Evaluation of the psychometric properties of the Turkish version of the Oral Assessment Sheet (OAS), including internal consistency, test-retest reliability, and construct validity in adults aged 60 years and older.

Trial sites (1)

FacilityCityRegionStatus
Necmettin Erbakan University Faculty of Dentistry Konya Konya Recruiting

More Necmettin Erbakan University trials in Turkey

Salivary Apelin, Chemerin, Ghrelin, and Lipocalin-2 Levels in Diabetic Patients With Periodontitis Recruiting
tVNS and Myofascial Release in Tinnitus Active, not recruiting
Changes in Periodontal Pocket Depth After Periodontal Treatment Recruiting
Selective Median Lobe Surgery Outcomes Study Starting soon
Web-Based End-of-Life and Post-Mortem Care Education for Nursing Students Starting soon

Other trials for the same condition

Effect of Hypochlorous Acid-containing Mouthwash on Healing After Impacted Wisdom Tooth Surgery Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07507864 on ClinicalTrials.gov ↗ ← All trials in Turkey